PTSM: Pharmaceutical Technology Sourcing and Management-02-01-2017

Analytical products for improved bio/pharmaceutical development.

Cloud-based information technology makes it easier for pharma companies and outsourcing partners to collaborate on quality, if risk-management steps are followed.

Rising R&D numbers and positive external funding for bio/pharma projects a strong outlook for the contract development and manufacturing market in 2017.

FDA issued approvals for less than half the number of new drugs in 2016 compared with 2015.

Gelatin is widely used for encapsulation, and requires close attention to “critical-to-quality” attributes.

SGS invested in test equipment for analyzing extractables and leachables at its New Jersey laboratory.

Vetter expanded visual inspection facilities and controlled-temperature storage at its Ravensburg Vetter West facility in Germany.

WuXi AppTech acquired HD Biosciences, a preclinical drug-discovery-focused CRO.

EAG Laboratories offers dermal absorption studies using OECD methods.

High Street Capital acquired Avomeen, a full-service chemical testing laboratory, in late December 2016

New website allows access to research quantities of commercial-grade ligands and catalysts.

B&W Tek’s director of Market and Customer Development, Katherine A. Bakeev, PhD, discusses analysis of pharmaceutical raw materials and the benefits of using handheld Raman spectrometers.

Catalent announces a development agreement with JOT to evaluate softgel options for a resveratrol drug candidate.